{"id":"https://openalex.org/W4387263098","doi":"https://doi.org/10.1158/0008-5472.c.6861233","title":"Data from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor\u2013Positive Metastatic Breast Cancers","display_name":"Data from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor\u2013Positive Metastatic Breast Cancers","publication_year":2023,"publication_date":"2023-10-02","ids":{"openalex":"https://openalex.org/W4387263098","doi":"https://doi.org/10.1158/0008-5472.c.6861233"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6861233","doi":"https://doi.org/10.1158/0008-5472.c.6861233","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6861233","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6861233","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017644527","display_name":"Juliana Navarro-Yepes","orcid":"https://orcid.org/0000-0003-0393-3773","observed_orcids":["https://orcid.org/0000-0003-0393-3773"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliana Navarro-Yepes","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0393-3773","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026936750","display_name":"Nicole M. Kettner","orcid":"https://orcid.org/0000-0003-2043-4407","observed_orcids":["https://orcid.org/0000-0003-2043-4407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole M. Kettner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2043-4407","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077700916","display_name":"Xiayu Rao","orcid":"https://orcid.org/0000-0001-5245-7449","observed_orcids":["https://orcid.org/0000-0001-5245-7449"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiayu Rao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5245-7449","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107385205","display_name":"Cassandra Santaella Bishop","orcid":"https://orcid.org/0000-0001-9153-9615","observed_orcids":["https://orcid.org/0000-0001-9153-9615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cassandra Santaella Bishop","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9153-9615","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000113218","display_name":"Tuyen N. Bui","orcid":"https://orcid.org/0000-0001-8509-3653","observed_orcids":["https://orcid.org/0000-0001-8509-3653"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tuyen N. Bui","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8509-3653","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052218127","display_name":"Hannah F. Wingate","orcid":"https://orcid.org/0000-0002-1055-8935","observed_orcids":["https://orcid.org/0000-0002-1055-8935"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hannah F. Wingate","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1055-8935","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016698215","display_name":"Akshara Singareeka Raghavendra","orcid":"https://orcid.org/0000-0002-6425-4400","observed_orcids":["https://orcid.org/0000-0002-6425-4400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akshara Singareeka Raghavendra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6425-4400","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057311999","display_name":"Yan Wang","orcid":"https://orcid.org/0000-0001-9566-8975","observed_orcids":["https://orcid.org/0000-0001-9566-8975"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9566-8975","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5398-0802","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041098535","display_name":"Ay\u015feg\u00fcl A. \u015eahin","orcid":"https://orcid.org/0000-0001-8259-9624","observed_orcids":["https://orcid.org/0000-0001-8259-9624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aysegul A. Sahin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8259-9624","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6816-6072","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017411324","display_name":"Kelly K. Hunt","orcid":"https://orcid.org/0000-0001-9156-8723","observed_orcids":["https://orcid.org/0000-0001-9156-8723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly K. Hunt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9156-8723","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009582590","display_name":"Senthil Damodaran","orcid":"https://orcid.org/0000-0002-2470-0891","observed_orcids":["https://orcid.org/0000-0002-2470-0891"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Senthil Damodaran","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2470-0891","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debu Tripathy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5711-2404","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5440-0849","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":1.0},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cdk4-6-inhibitor-resistance","display_name":"CDK4/6 inhibitor resistance","score":0.9470000267028809},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/her2-negative-metastatic-breast-cancer","display_name":"HER2-negative metastatic breast cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.6639999747276306},{"id":"https://openalex.org/keywords/oxidative-phosphorylation","display_name":"oxidative phosphorylation","score":0.9800000190734863},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8899999856948853},{"id":"https://openalex.org/keywords/organoids","display_name":"organoids","score":0.9190000295639038},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9598286151885986},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.623773992061615},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5717129111289978},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5601687431335449},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5313751101493835},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47694697976112366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4748416543006897},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.44123587012290955},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.391586571931839},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32640182971954346},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2835678458213806},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.062102288007736206},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6861233","doi":"https://doi.org/10.1158/0008-5472.c.6861233","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6861233","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6861233","doi":"https://doi.org/10.1158/0008-5472.c.6861233","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6861233","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4382541721","https://openalex.org/W4396587858","https://openalex.org/W4282935358","https://openalex.org/W3013833338","https://openalex.org/W2943341596","https://openalex.org/W4292866406","https://openalex.org/W4229063635","https://openalex.org/W4315490807","https://openalex.org/W4412974562","https://openalex.org/W4205928549"],"abstract_inverted_index":{"Abstract":[0],"Cyclin-dependent":[1],"kinases":[2,276],"4/6":[3,277],"inhibitor":[4],"(CDK4/6i)":[5],"plus":[6,29],"endocrine":[7],"therapy":[8,222],"(ET)":[9],"is":[10],"standard":[11],"of":[12,48,83,129,145,199,238,258],"care":[13],"for":[14,232,265],"patients":[15,106,162,201,204,266],"with":[16,35,163,181,189,205,267],"hormone":[17],"receptor":[18],"(HR)-positive,":[19],"HER2-negative":[20],"metastatic":[21,268],"breast":[22,114,165,249,269],"cancer":[23,115,166,270],"(MBC).":[24],"However,":[25],"resistance":[26,70],"to":[27,69,71,126,138,153,169,172,177,252],"CDK4/6is":[28,43,73],"ET":[30],"remains":[31],"a":[32,197,215,244,261],"clinical":[33,218,233],"problem":[34],"limited":[36],"therapeutic":[37,263],"options":[38],"following":[39,241,271],"disease":[40,63,272],"progression.":[41,64],"Different":[42],"might":[44],"have":[45],"distinct":[46,118],"mechanisms":[47],"resistance,":[49],"and":[50,75,86,99,112,120,136,151,157,254],"therefore":[51],"using":[52],"them":[53,125],"sequentially":[54],"or":[55],"targeting":[56],"their":[57],"differentially":[58],"altered":[59],"pathways":[60,67,135],"could":[61],"delay":[62],"To":[65],"understand":[66],"leading":[68],"the":[72,146,230,236],"palbociclib":[74,173],"abemaciclib,":[76,139],"we":[77],"generated":[78],"multiple":[79],"in":[80,94],"vitro":[81],"models":[82,159],"palbociclib-resistant":[84],"(PR)":[85],"abemaciclib-resistant":[87],"(AR)":[88],"cell":[89],"lines":[90],"as":[91,93],"well":[92],"vivo":[95,101],"patient-derived":[96],"xenografts":[97],"(PDX)":[98],"ex":[100],"PDX-derived":[102],"organoids":[103],"(PDxO)":[104],"from":[105,161,196,220],"who":[107,208],"progressed":[108,209],"on":[109,210,243,274],"CDK4/6i.":[110,246],"PR":[111,131,164],"AR":[113,141],"cells":[116,132,142],"exhibited":[117],"transcriptomic":[119],"proteomic":[121],"profiles":[122],"that":[123,203],"sensitized":[124],"different":[127],"classes":[128],"inhibitors;":[130],"upregulated":[133,143],"G2\u2013M":[134],"responded":[137,152],"while":[140,174],"mediators":[144],"oxidative":[147],"phosphorylation":[148],"pathway":[149],"(OXPHOS)":[150],"OXPHOS":[154],"inhibitors.":[155,278],"PDX":[156],"organoid":[158],"derived":[160],"remained":[167],"responsive":[168],"abemaciclib.":[170],"Resistance":[171],"maintaining":[175],"sensitivity":[176],"abemaciclib":[178,239,253],"was":[179,186],"associated":[180,188],"pathway-specific":[182,256],"transcriptional":[183],"activity":[184],"but":[185],"not":[187],"any":[190],"individual":[191],"genetic":[192],"alterations.":[193],"Finally,":[194],"data":[195],"cohort":[198],"52":[200],"indicated":[202],"HR-positive/HER2-negative":[206],"MBC":[207],"palbociclib-containing":[211],"regimens":[212],"can":[213],"exhibit":[214],"meaningful":[216],"overall":[217],"benefit":[219,237],"abemaciclib-based":[221],"when":[223],"administered":[224],"after":[225],"palbociclib.":[226],"These":[227],"findings":[228],"provide":[229],"rationale":[231],"trials":[234],"evaluating":[235],"treatment":[240],"progression":[242,273],"prior":[245],"Significance:":[247],"Palbociclib-resistant":[248],"cancers":[250],"respond":[251],"express":[255],"signatures":[257],"sensitivity,":[259],"providing":[260],"biomarker-driven":[262],"option":[264],"cyclin-dependent":[275]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-10-03T00:00:00"}